Company Announcements Office ASX ANNOUNCEMENT

4 June 2015

www.intgold.com.au

Company Announcements Office Australian Securities Exchange Level 6, 20 Bridge Street
SYDNEY NSW 2000

Via E Lodgement

WINTER GARDEN SIGNS RESEARCH AGREEMENT WITH NATIONAL UNIVERSITY OF URUGUAY

International Goldfields Limited ("IGS") (ASX:IGS) is pleased to advise that Winter Garden Bioscience ("Winter Garden" or "WG") has signed an exclusive, multi-year, renewable research agreement with the Science Faculty of the National University of Uruguay (Universidad de la Republica) to further research methodology associated with the development of the WG plant registration program. This research will involve genetic marker identification and synthetic seed propagation for Cannabis sativa sp.
WG is an emerging agriculture bioscience and biotechnology company in which IGS
has agreed to acquire an 85% interest (refer ASX announcement dated 1 May 2015).
Dr. Sabina Vidal, project manager for the Faculty of Science said: "Genetic markers are essential for the unequivocal identification of any given cultivar and its genetic relations to other cultivars which in turn is an integral part of plant registration."
The agreement concluded between WG and the UdlaR includes access to and collaboration with a private research institute (PCTP) where characterisation and product development work will be carried out. Coordinator of the project for the PCTP, Caterina Rufo, a Ph.D. in Food and Nutritional Science alongside Helena Pardo, a Ph.D. in Chemistry, will act as liaison between the PCTP and the technical management staff of WG.
The agreement blankets all facets of Cannabis and hemp, exclusively and at cost. Additionally it affords WG access to a team of PhD students, world renowned researchers and cutting edge equipment.
Winter Garden is currently the only company with the ability to research and internationally register varieties of Cannabis sativa sp. on a commercial level.
Relationships with governmental institutions such as the Universidad de la Republica are of great value to the research conducted at the company's laboratories and give the company the ability to move quickly towards the registration of new varieties.

Winter Garden Bioscience director Julian Strauss: "All our research and laboratory partners are strategically chosen to give us the ability to advance Winter Garden Bioscience's projects rapidly and create an environment that allows us to bring new

BOARD

Michael Edwards

Chairman

David Tasker

Director

Travis Schwertfeger

Director

COMPANY SECRETARY

Jane Flegg

REGISTERED OFFICE AND PRINCIPLE PLACE OF BUSINESS

Ground Floor, 1 Havelock Street

WEST PERTH WA 6005

PO Box 684

WEST PERTH WA 6872

COMMUNICATION DETAILS

Telephone: +61 8 9488 5220

Facsimile: +61 8 9324 2400

Web Address: www.intgold.com.au Email Address: info@intgold.com.au

AUSTRALIAN BUSINESS NUMBER

69 099 544 680

SHARE REGISTRY

Advanced Share

Registry Services Pty Ltd

150 Stirling Hwy

Nedlands WA 6009

MEDIA CONTACT

Tony Dawe

PPR

T: 08 9388 0944

E: tony.dawe@ppr.com.au

ASX CODE

IGS

www.intgold.com.au

registered varieties to our international partners, within a very short timeframe."

"With the existing relationships and the work done to date we anticipate registering our first varieties within next

10 months, which will create significant revenue opportunities for WG."

For and on behalf of the board

David Tasker
Director

FOR FURTHER INFORMATION, PLEASE CONTACT:

International Goldfields Professional Public Relations
T: +61 8 9488 5220 Tony Dawe
T: +61 8 9388 0944
M: +61 405 989 743
E: info@intgold.com.au E: tony.dawe@ppr.com.au

ABOUT WINTER GARDEN BIOSCIENCE

Winter Garden Bioscience is an advanced developer of mass market non-synthetic cannabis products, and is focused on the production of cannabis extracts, derivatives, delivery systems and related intellectual property for sale into the rapidly growing international marketplace for therapeutic medicinal cannabis products.

Winter Garden Bioscience is fully licensed to export cannabinoid products, including its high-potency CBD extracts. The Company plans to primarily target wholesale distribution partners which have developed CBD based product lines in the United States, Canada and Europe. This includes pharmaceutical and nutraceutical companies, in addition to companies focused on the marijuana marketplace. Winter Garden will also look at making its products available to retail consumers in North America and Europe which will supplement its wholesale revenues.
www.intgold.com.au

distributed by